Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
CALL
CSX Corp
CSX
$93.4B
| $2.85M | ﹤0.01% |
261,600
+2,400
| +0.9% | +$27.8K |
|
3452
Evogene
EVGN
$5.7M
| $2.85M | ﹤0.01% |
32,209
| – | – |
|
|
OUTR
3453
PUT
DELISTED
OUTERWALL INC
OUTR
| $2.85M | ﹤0.01% |
37,400
-299,800
| -89% | -$21.9M |
|
3454
CALL
Plains All American Pipeline
PAA
$17.3B
| $2.85M | ﹤0.01% |
65,300
+19,500
| +43% | +$935K |
|
3455
Wipro
WIT
$19.6B
| $2.84M | ﹤0.01% |
1,266,347
-41,754
| -3% | -$94.5K |
|
3456
Wintrust Financial
WTFC
$10.8B
| $2.84M | ﹤0.01% |
53,218
-1,967
| -4% | -$99.1K |
|
|
CUB
3457
DELISTED
Cubic Corporation
CUB
| $2.84M | ﹤0.01% |
59,665
+36,239
| +155% | +$1.78M |
|
3458
Medifast
MED
$109M
| $2.83M | ﹤0.01% |
87,530
+6,314
| +8% | +$200K |
|
|
ZNGA
3459
CALL
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $2.83M | ﹤0.01% |
989,300
+128,100
| +15% | +$358K |
|
|
EXAS
3460
CALL
DELISTED
Exact Sciences
EXAS
| $2.83M | ﹤0.01% |
95,100
-14,900
| -14% | -$374K |
|
|
ADXS
3461
DELISTED
Advaxis Inc
ADXS
| $2.83M | ﹤0.01% |
9,269
+6,420
| +225% | +$2.03M |
|
3462
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$150M
| $2.82M | ﹤0.01% |
30,981
-4,702
| -13% | -$502K |
|
3463
CALL
Ross Stores
ROST
$80.5B
| $2.81M | ﹤0.01% |
57,900
-9,100
| -14% | -$457K |
|
|
IGTE
3464
DELISTED
IGATE CORPORATION
IGTE
| $2.81M | ﹤0.01% |
58,935
+51,666
| +711% | +$2.39M |
|
3465
PUT
Elevance Health
ELV
$81.5B
| $2.81M | ﹤0.01% |
17,100
-7,400
| -30% | -$1.18M |
|
3466
PUT
Alaska Air
ALK
$5.29B
| $2.8M | ﹤0.01% |
43,500
+9,300
| +27% | +$599K |
|
|
YOKU
3467
PUT
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
| $2.8M | ﹤0.01% |
114,100
+7,200
| +7% | +$163K |
|
|
TLMR
3468
DELISTED
TALMER BANCORP INC (MI)
TLMR
| $2.8M | ﹤0.01% |
166,942
+72,348
| +76% | +$1.17M |
|
3469
CALL
W.W. Grainger
GWW
$65.3B
| $2.79M | ﹤0.01% |
11,800
-800
| -6% | -$194K |
|
3470
WisdomTree
WT
$2.96B
| $2.79M | ﹤0.01% |
127,059
+17,383
| +16% | +$367K |
|
3471
PUT
ResMed
RMD
$30.6B
| $2.79M | ﹤0.01% |
49,500
+48,300
| +4,025% | +$3.05M |
|
|
KBAL
3472
DELISTED
Kimball International
KBAL
| $2.79M | ﹤0.01% |
228,992
+21,515
| +10% | +$248K |
|
|
DDC
3473
DELISTED
Dominion Diamond Corporation
DDC
| $2.78M | ﹤0.01% |
198,580
+13,181
| +7% | +$239K |
|
|
FMI
3474
DELISTED
Foundation Medicine, Inc.
FMI
| $2.77M | ﹤0.01% |
82,018
+27,862
| +51% | +$1.12M |
|
3475
Calix
CALX
$2.26B
| $2.77M | ﹤0.01% |
364,184
-3,885
| -1% | -$31.7K |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.